Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 26 P579

ECE2011 Poster Presentations Cardiovascular endocrinology and lipid metabolism (34 abstracts)

Correlation of atherogenic dyslipidemia with other plaque instability biomarkers and outcome in non ST-segment elevation acute coronary syndromes (NSTE-ACS)

Elena Bobescu 1, , Alina Mihaela Pascu 1, , Mariana Radoi 1, , Georgeta Datcu 3 , Dan Dobreanu 4 , Gheorghe Ioan Totoianu 5 , Mihaela Stanciu 5 & Ovidiu Burta 6


1Transilvania University Brasov, Faculty of Medicine, Brasov, Romania; 2Clinical Emergency County Hospital Brasov, Brasov, Romania; 3Grigore T. Popa University of Medicine and Pharmacy Iasi, Iasi, Romania; 4University of Medicine and Pharmacy Targu Mures, Targu Mures, Romania; 5Lucian Blaga University Sibiu, Faculty of Medicine, Sibiu, Romania; 6Faculty of Medicine and Pharmacy Oradea, Oradea, Romania.


Introduction: Atheromatous plaque instability biomarkers are the most important predictors for the evolution with major acute cardiovascular events (MACE) in patients with NSTE-ACS.

Objective: To evaluate the impact of dyslipidemia, endothelial dysfunction, oxidative stress, platelet hyperactivity and hypercoagulable state and their inter-correlation on the outcome of NSTE-ACS.

Methods: Two hundred and forty patients with NSTE-ACS, 154 (64.17%) men, mean age 58.31±8.92, were investigated for dyslipidemia (LDL-Cholesterol>100 md/dl, HDL-Cholesterol<50 mg/dl (men) and <40 mg/dl (women)), oxidative stress [total antioxidant status<1.3 mmol/l, Myeloperoxidase (MPO) (IgG ELISA)>20 U), hypercoagulable state (Von-Willebrand factor activity>169.7%, Protein C<70%, Protein S<72.2%, Antithrombin<71%, Factor V Leiden – APC Resistance V ratio<2.18), and platelet hyperactivity (multiple electrode aggregometry aspirin test (ASPItest)>30 U, and adenosine diphosphate test (ADPtest)>50 U), and were followed up for MACE (cardiovascular death, non-fatal myocardial infarction, recurrent angina with readmission, stroke) during 1 year. Local Ethics Committee approved the study protocol.

Statistics: SPSS 16.0.

Results: Except for the stoke, the incidence of MACE in patients with NSTE-ACS was significantly correlated with high LDL-Chol (r=0.74, P<0.0001), and low HDL-Chol levels (r=0.65, P<0.001), low serum total antioxidant status (r=0.69, P<0.0001), hypercoagulable state (r=0.63, P<0.001), and platelet hyperactivity (r=0.53, P<0.01). In patients with NSTE-ACS and MACE from our study group, a high LDL-Chol level (>100 mg/dl) and a low HDL-Chol level (<50 mg/dl in men and <40 mg/dl in women) were both best correlated with a low total antioxidant status (r=0.63, P<0.001; r=0.54, P=0.02).

Conclusion: In patients with NSTE-ACS from our study group atherogenic dyslipidemia was significantly correlated with endothelial dysfunction, oxidative stress and platelet hyperactivity biomarkers, and with MACE at 1-year follow-up.

This work was supported by CNCSIS-UEFISCU, Project number NII-ID_727/2008

Article tools

My recent searches

No recent searches.